Roberta Parente

Dr. Roberta Parente

Dipartimento di Medicina, Chirurgia e Odontoiatria, Università degli Studi di Salerno, Salerno, Italy
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
Enrico HefflerEnrico Heffler
Enrico Heffler
Francesco BlasiFrancesco Blasi
Francesco Blasi
MLManuela Latorre
Manuela Latorre
FMFrancesco Menzella
Francesco Menzella
PPPierluigi Paggiaro
Pierluigi Paggiaro
GSGiuseppe Spadaro
Giuseppe Spadaro

1 October 2016 in Immunology Letters
Verified
Journal Article
Closed access
CCChiara Cardamone
Chiara Cardamone
RPRoberta Parente
Roberta Parente
GFGiulia De Feo
Giulia De Feo
Massimo TriggianiMassimo Triggiani
Massimo Triggiani

12 February 2018 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
KKKenji Kabashima
Kenji Kabashima
CNChisa Nakashima
Chisa Nakashima
YNYumi Nonomura
Yumi Nonomura
AOAtsushi Otsuka
Atsushi Otsuka
CCChiara Cardamone
Chiara Cardamone
Massimo TriggianiMassimo Triggiani
Massimo Triggiani

16 March 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
JTJakub Trizuljak
Jakub Trizuljak
WSWolfgang R. Sperr
Wolfgang R. Sperr
LNLucie Nekvindová
Lucie Nekvindová
HEHanneke Oude Elberink
Hanneke Oude Elberink
KGKaroline V. Gleixner
Karoline V. Gleixner
Peter ValentPeter Valent
Peter Valent

26 January 2018 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
MBMaria Bova
Maria Bova
GFGiulia De Feo
Giulia De Feo
RPRoberta Parente
Roberta Parente
TPTiziana De Pasquale
Tiziana De Pasquale
CGCarmela Gravante
Carmela Gravante
Massimo TriggianiMassimo Triggiani
Massimo Triggiani
Recurrent angioedema (AE) without wheals is increasingly recognized as a clinical entity and a frequent cause of admission to the emergency room. The Hereditary Angioedema Working Group (HAWK) classification allowed the scientific community to go beyond the semantic confusion that dominated this topic for decades. This classification distinguishes hereditary and acquired forms of AE, either related or unrelated to C1 inhibitor deficiency. Recently, additional mechanisms have been involved in the AE pathogenesis, including the uncontrolled activation of factor XII, generation of vasoactive mediators that induce dysregulation of endothelial functions, and bidirectional interactions between mast cell-derived mediators and the plasma contact system. Thus, recurrent AE can be determined by multiple and concurrent mechanisms that may generate distinct clinical phenotypes of the disease. Frequency, severity, and the location of attacks are quite different from patient to patient and, even in the same patient, they may change throughout the course of life. The severity of the clinical phenotype strongly influences the burden of the disease and patients’ quality of life. Despite major advances in our understanding of recurrent AE, many unsolved questions remain, leaving several unmet needs for patients and caregivers. This review is focused on a description of different AE phenotypes and the concurrent mechanisms leading to their pathogenesis. A better definition of cellular and molecular pathways responsible for the distinct AE phenotypes may help to improve diagnosis and may lead to a personalized approach to prophylaxis and treatment of the disease.

1 January 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
Peter ValentPeter Valent
Peter Valent
JEJoanna N.G. Oude Elberink
Joanna N.G. Oude Elberink
AGAleksandra Maria Górska
Aleksandra Maria Górska
MLMagdalena Lange
Magdalena Lange
RZRoberta Zanotti
Roberta Zanotti
WSWolfgang R. Sperr
Wolfgang R. Sperr